期刊文献+

低血清总胆红素水平预测冠心病发病危险的探讨 被引量:1

The study of predicting cornary heart disease with low level of total bilirubin
下载PDF
导出
摘要 目的确定低血清总胆红素(TBIL)水平与冠心病(CHD)之间关系,对低血清总胆红素水平预测冠心病发病危险参考值范围的界定进行探讨。方法使用RXL和BAYER1650生化分析仪测定冠心病患者、正常对照组及正常体检人群的血清总胆红素;使用病例-对照研究设计的2×2表资料及对应的统计学分析方法对数据和资料进行分析,使用百分位数法并结合不同血清总胆红素暴露水平与冠心病的关系来界定低血清总胆红素水平预测冠心病发病危险的参考值范围和危险水平临界值。结果冠心病患者血清总胆红素水平为(8.98±4.26)μmol/L,正常对照组血清总胆红素水平为(13.61±5.78)μmol/L,两组血清TBIL水平有显著性差异(u=6.12,P<0.01);正常体检人群血清总胆红素水平为(13.89±5.82),低血清总胆红素水平预测冠心病发病危险的参考值范围为TBIL≤10.80μmol/L。结论低血清TBIL水平与冠心病的发病之间存在相关性,初步得到本实验室低血清总胆红素水预测冠心病发病危险的参考值范围。 Objective To study the relationship between low level of serum total bilirubin(TBIL) and coruary heart disease(CHD), and establish the reference value for predicting CHD with low level of TBIL. Methods RXL and BAYER1650 biochemical analyzer were used to detect serum total bilirubin of CHD, healthy people and the persons for physical exanimation. All of data was analyzed by some related statistic methods such as 2×2 table's and odds ration to determine the reference value for predicting CHD. Results The TBIL level of CHD was 8.98±4.26umol/L and the healthy people was 13.61±5.78umol/L. Both was significantly difference (u=6.12, P〈0.01). The TBIL level of the persons for physical exanimation ,was 13.89±5.82umol/L. Lower than 10.80umol/L of TBIL was possible to prompt CHD. Conclusion Low level of TBIL is related to CHD, and lower than 10.80umol/L can be used to predict CHD.
出处 《实验与检验医学》 CAS 2008年第6期589-592,共4页 Experimental and Laboratory Medicine
基金 东莞市科技局立项项目200565
关键词 冠心病 血清总胆红素 参考范围 Cornary heart disease Total hilirubin Reference value
  • 相关文献

参考文献17

  • 1[1]Madhavan M,Wattigeng WA,Srinivasan SR,et al.Serum bilirubin distribution and its relation to cardiovascular[J].Atherosclerosis,1997,131:107-103.
  • 2[2]Stocker R,Glazer AN,Ames BN.Antioxidatant activity of albun in-bound bitirubin[J].Proc Natl Acad Sic USA,1987,84:5919-5922.
  • 3[3]Schwerther HA,Jackson WC,Tolan G.Association If low serum concentration If bilirubin with increased risk If coronary Artery disease[J].Clin Chem,1994,40:18-23.
  • 4[4]Ross R.Atherosclerosis-an inflammatory disease]J].N Engl J Med,1999,340(2):115-126.
  • 5[5]Santiago E,Mora L,Bautista M,et al.Granulocyte colony-stimulating factor induces neutmphils to secrete macrophage colony-stimulating factor[J].Cytokine,2001,15(6):299-304.
  • 6[6]Mayer M.Association of serum bilirubin concentration with risk of coronary artery disease]J].Clin Chem,2004,46(4):1723-1727.
  • 7刘显初,郑利平,黄胜贤,杜贤,阳茂春,马升俊,朱旭,王第惠.冠心病血清总胆红素与氧化修饰低密度脂蛋白的关系研究[J].中华检验医学杂志,2003,26(8):479-480. 被引量:45
  • 8[8]Yamagachi T,Terkado M,Horio F,teal.Role of bilirubin as an antioxidant in ischemia-reperfusion of rat liver and induction of heme oxyenase[J].Biochme Biophys Res Commun,2005,223(5):129-135.
  • 9[9]Kram LP,Potockova J,Kopriva H,et al.Ferritin,Oxidative stress and coronary atherosclerasis[J].VnitrLek,2004,50(3):197-202.
  • 10[10]Sharma HS,Dsa DK,Verdouw PD.Enhanced expression and localization of heme oxygenase-1 during recovery phase of porcine stunned myocacdium[J].Mol Cell Biochem,1999,196(1-2):133-139.

二级参考文献24

  • 1陈瑗,周玫.LDL的氧化修饰和氧化修饰LDL的组成和结构变化[J].生物物理学报,1993,9(2):334-340. 被引量:16
  • 2杨昌国,李清华,许叶.载脂蛋白AI和B的免疫浊度自动分析法[J].临床检验杂志,1995,13(6):287-290. 被引量:9
  • 3王抒,李健斋,赵淑华,唐蔚青,褚德发,李培瑛,满咏,李红霞.血清载脂蛋白参考值[J].中华医学检验杂志,1996,19(6):343-348. 被引量:30
  • 4张西洲 何富文 康雪文 等.高海拔居住及返回平原后RBC-SOD和GHS—PX的改变[J].中华内科杂志,1994,(7):448-448.
  • 5Hopkins P N,Arterioscler Thromb Vasc Biol,1996年,16卷,250页
  • 6Wu T W,Life Sci,1994年,54卷,477页
  • 7Jungner I, Marcovina SM, Walldius G, Holme I, Kolar W, Steiner E. Apolipoprotein B and A1 values in 147 576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials[J]. Clin Chem, 1998,44 (8):1641-649
  • 8Averina M, Nilssen O, Brenn T. Factora behind the increase in cardiovascular mortality in Russia: Apolipoprotein AⅠ and B distribution in the Arkhagelsk study 2000[J]. Clin Chem, 2004, 50(2):346-54
  • 9Bachorik PS, Lovejoy KL, Carroll MD, Johnson CL. Apolipoprotein B and AⅠ distributions in the United States, 1988-1991: results of the National Health and Nutrifion Examinafion Survey Ⅲ(NHANES Ⅲ)[J]. Clin Chem, 1997,43(12):2364-378
  • 10Contois JH, Mcnamara JR, Lammi-Keefe CJ, Wilson PWF, Massov T, Schaefer EJ. Reference intervals for plasma apolipoprotein A1 determined with a sfandardized commerercial immunoturbidimetric assay: result from the Framingham Offspring Study[J]. Clin Chem, 1996,42(4):507-514

共引文献102

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部